Skip to main content
. 2021 Feb 22;16(2):e0246937. doi: 10.1371/journal.pone.0246937

Table 2. Antimicrobial susceptibility profiles of the C-NS bacterial isolates.

Isolate ID Antibiotic susceptibility test MICs in μg/mL (Interpretation)
MEM CRO PIP TIM FEP LVX TET MIN TGC
Acinetobacter baumannii (n = 27)
KAB1 > = 16 (R) > = 64 (R) > = 128 (R) > = 128 (R) > = 64 (R) > = 8 (R) > = 16 (R) 4 (S) 1 (S)
KAB2 > = 16 (R) > = 64 (R) > = 128 (R) > = 128 (R) > = 64 (R) > = 8 (R) > = 16 (R) 4 (S) 1 (S)
KAB3 > = 16 (R) > = 64 (R) > = 128 (R) nd > = 64 (R) > = 8 (R) > = 16 (R) 4 (S) 1 (S)
KAB4 > = 16 (R) > = 64 (R) > = 128 (R) > = 128 (R) > = 64 (R) > = 8 (R) > = 16 (R) > = 16 (R) > = 8 (R)
KAB5 > = 16 (R) > = 64 (R) > = 128 (R) > = 128 (R) > = 64 (R) > = 8 (R) > = 16 (R) 4 (S) 2 (S)
KAB6 > = 16 (R) > = 64 (R) > = 128 (R) > = 128 (R) > = 64 (R) > = 8 (R) > = 16 (R) > = 16 (R) 4 (I)
KAB7 > = 16 (R) > = 64 (R) > = 128 (R) > = 128 (R) > = 64 (R) > = 8 (R) > = 16 (R) 8 (I) 2 (S)
KAB8 > = 16 (R) > = 64 (R) > = 128 (R) > = 128 (R) > = 64 (R) 0.5 (S) > = 16 (R) < = 1 (S) 2 (S)
KAB9 > = 16 (R) > = 64 (R) > = 128 (R) > = 128 (R) > = 64 (R) > = 8 (R) > = 16 (R) 8 (I) 2 (S)
KAB10 > = 16 (R) > = 64 (R) > = 128 (R) > = 128 (R) > = 64 (R) > = 8 (R) > = 16 (R) 8 (I) 2 (S)
KAB11 > = 16 (R) > = 64 (R) > = 128 (R) > = 128 (R) > = 64 (R) > = 8 (R) > = 16 (R) 8 (I) 2 (S)
KAB12 > = 16 (R) > = 64 (R) > = 128 (R) > = 128 (R) > = 64 (R) > = 8 (R) > = 16 (R) 2 (S) 2 (S)
KAB13 > = 16 (R) > = 64 (R) > = 128 (R) > = 128 (R) > = 64 (R) 4 (R) > = 16 (R) > = 16 (R) 2 (S)
KAB14 8 (I) > = 64 (R) > = 128 (R) > = 128 (R) > = 64 (R) 4 (R) > = 16 (R) < = 1 (S) < = 0.5 (S)
KAB15 4 (I*) > = 64 (R) > = 128 (R) > = 128 (R) > = 64 (R) 4 (R) 2 (S) < = 1 (S) < = 0.5 (S)
KAB16 8 (I) > = 64 (R) > = 128 (R) > = 128 (R) > = 64 (R) 4 (R) 4 (S) < = 1 (S) < = 0.5 (S)
KAB17 > = 16 (R) > = 64 (R) > = 128 (R) > = 128 (R) > = 64 (R) < = 0.12 (S) 4 (S) < = 1 (S) 1 (S)
KAB18 > = 16 (R) > = 64 (R) > = 128 (R) > = 128 (R) > = 64 (R) < = 0.12 (S) 4 (S) < = 1 (S) 1 (S)
KAB19 > = 16 (R) > = 64 (R) > = 128 (R) > = 128 (R) > = 64 (R) 0.25 (S) 8(I) 2 (S) 4 (I)
KAB20 > = 16 (R) > = 64 (R) > = 128 (R) > = 128 (R) > = 64 (R) < = 0.12 (S) 4 (S) < = 1 (S) < = 0.5 (S)
KAB21 > = 16 (R) > = 64 (R) > = 128 (R) > = 128 (R) > = 64 (R) < = 0.12 (S) 4 (S) < = 1 (S) < = 0.5 (S)
KAB22 > = 16 (R) > = 64 (R) > = 128 (R) > = 128 (R) > = 64 (R) < = 0.12 (S) 4 (S) 2 (S) 1 (S)
KAB23 > = 16 (R) > = 64 (R) > = 128 (R) > = 128 (R) > = 64 (R) < = 0.12 (S) 4 (S) < = 1 (S) 1 (S)
KAB24 > = 16 (R) > = 64 (R) > = 128 (R) > = 128 (R) > = 64 (R) < = 0.12 (S) 4 (S) 2 (S) < = 0.5 (S)
KAB25 > = 16 (R) > = 64 (R) > = 128 (R) > = 128 (R) > = 64 (R) 4 (R) > = 16 (R) > = 16 (R) 1 (S)
KAB26 > = 16 (R) > = 64 (R) > = 128 (R) > = 128 (R) > = 64 (R) 4 (R) > = 16 (R) > = 16 (R) 2 (S)
KAB27 > = 16 (R) > = 64 (R) > = 128 (R) > = 128 (R) > = 64 (R) 4 (R) 8 (I) > = 16 (R) 2 (S)
Enterobacter cloacae (n = 2)
KEB1 > = 16 (R) > = 64 (R) > = 128 (R) > = 128 (R) > = 64 (R) > = 8 (R) > = 16 (R) > = 16 (R) 2 (S)
KEB2 > = 16 (R) > = 64 (R) > = 128 (R) > = 128 (R) 32 (R) 0.25 (S) 4 (S) > = 16 (R) 2 (S)
Escherichia coli (n = 3)
KEC1 8 (R) > = 64 (R) > = 128 (R) > = 128 (R) > = 64 (R) > = 8 (R) > = 16 (R) > = 16 (R) < = 0.5 (S)
KEC2 8 (R) > = 64 (R) > = 128 (R) > = 128 (R) > = 64 (R) > = 8 (R) > = 16 (R) > = 16 (R) < = 0.5 (S)
KEC3 8 (R) > = 64 (R) > = 128 (R) > = 128 (R) > = 64 (R) > = 8 (R) > = 16 (R) > = 16 (R) < = 0.5 (S)
Klebsiella pneumoniae(n = 2)
KKPI > = 16 (R) > = 64 (R) > = 128 (R) > = 128 (R) > = 64 (R) > = 8 (R) > = 16 (R) > = 16 (R) > = 8 (R)
KKP2 > = 16 (R) > = 64 (R) > = 128 (R) > = 128 (R) 16 (R) 1 (S) > = 16 (R) 4 (S) < = 0.5 (S)
Pseudomonas aeruginosa(n = 14)
KPA1 > = 8 (R)# nd >64 (R) # nd >8 (R) # > = 4 (R) # nd nd nd
KPA2 > = 16 (R) nd > = 128 (R) > = 128 (R) > = 64 (R) > = 8 (R) nd nd > = 8 (R)
KPA3 > = 16 (R) nd 64 (R) > = 128 (R) 8 (S) > = 8 (R) nd nd > = 8 (R)
KPA4 > = 16 (R) nd > = 128 (R) > = 128 (R) > = 64 (R) > = 8 (R) nd nd > = 8 (R)
KPA5 > = 16 (R) nd > = 128 (R) > = 128 (R) > = 64 (R) > = 8 (R) nd nd > = 8 (R)
KPA6 > = 16 (R) nd > = 128 (R) > = 128 (R) > = 64 (R) > = 8 (R) nd nd > = 8 (R)
KPA7 > = 16 (R) nd > = 128 (R) > = 128 (R) > = 64 (R) > = 8 (R) nd nd > = 8 (R)
KPA8 > = 16 (R) nd > = 128 (R) > = 128 (R) > = 64 (R) > = 8 (R) nd nd > = 8 (R)
KPA9 > = 16 (R) nd > = 128 (R) > = 128 (R) > = 64 (R) > = 8 (R) nd nd > = 8 (R)
KPA10 > = 8 (R) nd > = 128 (R) > = 128 (R) > = 64 (R) > = 8 (R) nd nd > = 8 (R)
KPA11 > = 8 (R) nd > = 128 (R) > = 128 (R) > = 64 (R) > = 8 (R) nd nd > = 8 (R)
KPA12 > = 16 (R) nd > = 128 (R) > = 128 (R) > = 64 (R) > = 8 (R) nd nd > = 8 (R)
KPA13 > = 16 (R) nd > = 128 (R) > = 128 (R) > = 64 (R) > = 8 (R) nd nd > = 8 (R)
KPA14 > = 8 (R) nd > = 128 (R) > = 128 (R) > = 64 (R) > = 8 (R) nd nd > = 8 (R)
No. tested 48 34 48 46 48 48 34 34 47
No. susceptible (S) 0 0 0 0 1 11 10 18 31
% S 0.0 0.0 0.0 0 2.1 22.9 29.4 52.9 66.0

MIC values that indicate non-susceptibility to the antibiotic are shaded grey.

The %S is the number of susceptible isolates as a percentage of all isolates tested for each antibiotic.

MIC, minimum inhibitory concentration; CRO, ceftriaxone; FEP, cefepime; TIM, ticarcillin-clavulanic acid; PIP, piperacillin; MEM, meropenem; LVX, levofloxacin; TET, tetracycline; TGC, tigecycline; MIN, minocycline; nd, antibiotics not tested.

*Non-susceptibility inferred by the VITEK 2® AES system.

# AST performed on a Microscan platform.